Global Burden of Diseases Attributable to Early Maturation in 2021

Abstract

Early maturation poses a considerable health challenge worldwide. We aim to quantify the global disease burden attributable to early maturation in 2021. We calculated sex-specific and region-specific population attributable fractions (PAFs) of diseases through meta-analysis and Mendelian randomization. The age-standardized incidence rate (ASIR) with 95% uncertainty intervals (UIs) of these diseases, stratified by sex, age, and development status were estimated using the Global Burden of Diseases database. Asthma, Type 2 diabetes, ischemic heart disease, stroke, uterine cancer, testicular cancer, and depression was causally related with early maturation, with PAF ranging from 7.7% for uterine cancer to 0.8% for Type 2 diabetes. About 11.2 million new attributable cases occurs, with an ASIR of 210.1 (95% UI 155.1–280.7) cases per 100,000, with higher PAF in females (3.4%) than in males (2.3%). The ASIR was highest in North America (405.5, 309.0–526.3 cases per 100,000) and lowest in East Asia and the Pacific (120.8, 89.6–160.3 cases per 100,000). More developed regions showed 1.4 times higher incidence burden (ASIR 268.5, 199.6–356.6 cases per 100,000) than less developed regions. Therefore, regional adoption of effective public health interventions to alleviate early maturation, notably for females in more developed regions, has enormous potential to reduce worldwide disease burden.

Keywords

age-standardized incidence / early maturation / global burden / population attributable fraction

References

[1] J. Wise, “Puberty Timing Has Profound Effect on Later Health, Study Finds,” BMJ 350 (2015): h3318.

[2] C. Eckert-Lind, A. S. Busch, J. H. Petersen, et al., “Worldwide Secular Trends in Age at Pubertal Onset Assessed by Breast Development Among Girls: A Systematic Review and Meta-Analysis,” JAMA Pediatrics 174, no. 4 (2020): e195881.

[3] F. F. Chen, Y. F. Wang, and J. Mi, “Timing and Secular Trend of Pubertal Development in Beijing Girls,” World Journal of Pediatrics 10, no. 1 (2014): 74–79.

[4] T. Cheng, F. R. Day, R. Lakshman, and K. K. Ong, “Association of Puberty Timing With Type 2 Diabetes: A Systematic Review and Meta-Analysis,” PLoS Medicine 17, no. 1 (2020): e1003017.

[5] K. Okoth, J. S. Chandan, T. Marshall, et al., “Association Between the Reproductive Health of Young Women and Cardiovascular Disease in Later Life: Umbrella Review,” BMJ 371 (2020): m3502.

[6] B. J. Fuhrman, S. C. Moore, C. Byrne, et al., “Association of the Age at Menarche With Site-Specific Cancer Risks in Pooled Data From Nine Cohorts,” Cancer Research 81, no. 8 (2021): 2246–2255.

[7] M. Cao and B. Cui, “Negative Effects of Age at Menarche on Risk of Cardiometabolic Diseases in Adulthood: A Mendelian Randomization Study,” Journal of Clinical Endocrinology & Metabolism 105, no. 2 (2020): 515–522.

[8] F. R. Day, D. J. Thompson, H. Helgason, et al., “Genomic Analyses Identify Hundreds of Variants Associated With Age at Menarche and Support a Role for Puberty Timing in Cancer Risk,” Nature Genetics 49, no. 6 (2017): 834–841.

[9] W. Xing, Q. Lv, Y. Li, et al., “Genetic Prediction of Age at Menarche, Age at Natural Menopause and Type 2 Diabetes: A Mendelian Randomization Study,” Nutrition, Metabolism and Cardiovascular Diseases 33, no. 4 (2023): 873–882.

[10] IHME, “Global Burden of Disease (GDB),” University of Washington, 2020, https://www.healthdata.org/research-analysis/gbd.

[11] C. Minelli, D. A. van der Plaat, B. Leynaert, et al., “Age at Puberty and Risk of Asthma: A Mendelian Randomisation Study,” PLoS Medicine 15, no. 8 (2018): e1002634.

[12] E. L. Ding, Y. Song, J. E. Manson, et al., “Sex Hormone-Binding Globulin and Risk of Type 2 Diabetes in Women and Men,” New England Journal of Medicine 361, no. 12 (2009): 1152–1163.

[13] J. A. Resztak, J. Choe, S. Nirmalan, et al., “Analysis of Transcriptional Changes in the Immune System Associated With Pubertal Development in a Longitudinal Cohort of Children With Asthma,” Nature Communications 14, no. 1 (2023): 230.

[14] S. E. Mouridsen and F. W. Larsen, “Psychological Aspects of Precocious Puberty. An Overview,” Acta Paedopsychiatrica 55, no. 1 (1992): 45–49.

[15] F. Islami, A. Goding Sauer, K. D. Miller, et al., “Proportion and Number of Cancer Cases and Deaths Attributable to Potentially Modifiable Risk Factors in the United States,” CA: A Cancer Journal for Clinicians 68, no. 1 (2018): 31–54.

[16] F. Valent, D. Little, R. Bertollini, L. E. Nemer, F. Barbone, and G. Tamburlini, “Burden of Disease Attributable to Selected Environmental Factors and Injury Among Children and Adolescents in Europe,” Lancet 363, no. 9426 (2004): 2032–2039.

[17] C. D. Mathers and D. Loncar, “Projections of Global Mortality and Burden of Disease From 2002 to 2030,” PLoS Medicine 3, no. 11 (2006): e442.

[18] COVID 19 Mental Disorders Collaborators, “Global Prevalence and Burden of Depressive and Anxiety Disorders in 204 Countries and Territories in 2020 Due to the COVID-19 Pandemic,” Lancet 398, no. 10312 (2021): 1700–1712.

[19] A. S. F. Kwong, D. Manley, N. J. Timpson, et al., “Identifying Critical Points of Trajectories of Depressive Symptoms From Childhood to Young Adulthood,” Journal of Youth and Adolescence 48, no. 4 (2019): 815–827.

[20] World Health Organization, “Comprehensive Mental Health Action Plan 2013–2030,” published 21 September, 2021, https://www.who.int/publications/i/item/9789240031029.

[21] A. E. Moran, M. H. Forouzanfar, G. A. Roth, et al., “Temporal Trends in Ischemic Heart Disease Mortality in 21 World Regions, 1980 to 2010: The Global Burden of Disease 2010 Study,” Circulation 129, no. 14 (2014): 1483–1492.

[22] GBD 2019 Stroke Collaborators, “Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019,” Lancet Neurology 20, no. 10 (2021): 795–820.

[23] NCD Risk Factor Collaboration (NCD-RisC), “Worldwide Trends in Body-Mass Index, Underweight, Overweight, and Obesity From 1975 to 2016: A Pooled Analysis of 2416 Population-Based Measurement Studies in 128·9 Million Children, Adolescents, and Adults,” Lancet 390, no. 10113 (2017): 2627–2642.

[24] H. N. Gouda, F. Charlson, K. Sorsdahl, et al., “Burden of Non-Communicable Diseases in Sub-Saharan Africa, 1990-2017: Results From the Global Burden of Disease Study 2017,” Lancet Global Health 7, no. 10 (2019): e1375–e1387.

[25] D. Talukdar, S. Seenivasan, A. J. Cameron, and G. Sacks, “The Association Between National Income and Adult Obesity Prevalence: Empirical Insights Into Temporal Patterns and Moderators of the Association Using 40 Years of Data Across 147 Countries,” PLoS One 15, no. 5 (2020): e0232236.

[26] B. A. Swinburn, G. Sacks, K. D. Hall, et al., “The Global Obesity Pandemic: Shaped by Global Drivers and Local Environments,” Lancet 378, no. 9793 (2011): 804–814.

[27] T. Leone and L. J. Brown, “Timing and Determinants of Age at Menarche in Low-Income and Middle-Income Countries,” BMJ Global Health 5, no. 12 (2020): e003689.

[28] L. Xie, Q. Tang, D. Yao, et al., “Effect of Decaffeinated Green Tea Polyphenols on Body Fat and Precocious Puberty in Obese Girls: A Randomized Controlled Trial,” Frontiers in Endocrinology 12 (2021): 736724.

[29] S. J. Semaan and A. S. Kauffman, “Developmental Sex Differences in the Peri-Pubertal Pattern of Hypothalamic Reproductive Gene Expression, Including Kiss1 and Tac2, May Contribute to Sex Differences in Puberty Onset,” Molecular and Cellular Endocrinology 551 (2022): 111654.

[30] C. M. Beall, “Two Routes to Functional Adaptation: Tibetan and Andean High-Altitude Natives,” Proceedings of the National Academy of Sciences of the United States of America 104, no. S1 (2007): 8655–8660.

[31] S. J. Ulijaszek, “Human Eating Behaviour in an Evolutionary Ecological Context,” Proceedings of the Nutrition Society 61, no. 4 (2002): 517–526.

[32] G. H. Perry, N. J. Dominy, K. G. Claw, et al., “Diet and the Evolution of Human Amylase Gene Copy Number Variation,” Nature Genetics 39, no. 10 (2007): 1256–1260.

[33] GBD 2021 Adolescent BMI Collaborators, “Global, Regional, and National Prevalence of Child and Adolescent Overweight and Obesity, 1990-2021, With Forecasts to 2050: A Forecasting Study for the Global Burden of Disease Study 2021,” Lancet 405, no. 10481 (2025): 785–812.

[34] GBD 2019 Dementia Forecasting Collaborators, “Estimation of the Global Prevalence of Dementia in 2019 and Forecasted Prevalence in 2050: An Analysis for the Global Burden of Disease Study 2019,” Lancet Public Health 7, no. 2 (2022): e105–e125.

[35] G. A. Stevens, L. Alkema, R. E. Black, et al., “Guidelines for Accurate and Transparent Health Estimates Reporting: The GATHER Statement,” Lancet 388, no. 10062 (2016): e19–e23.

[36] S. A. Berenbaum, A. M. Beltz, and R. Corley, “The Importance of Puberty for Adolescent Development: Conceptualization and Measurement,” Advances in Child Development and Behavior 48 (2015): 53–92.

[37] F. R. Day, C. E. Elks, A. Murray, K. K. Ong, and J. R. Perry, “Puberty Timing Associated With Diabetes, Cardiovascular Disease and Also Diverse Health Outcomes in Men and Women: The UK Biobank Study,” Scientific Reports 5 (2015): 11208.

[38] E. Hwang, K. W. Lee, Y. Cho, H. K. Chung, and M. J. Shin, “Association Between Age at Menarche and Diabetes in Korean Post-Menopausal Women: Results From the Korea National Health and Nutrition Examination Survey (2007-2009),” Endocrine Journal 62, no. 10 (2015): 897–905.

[39] J. Bremner, A. Frost, C. Haub, M. Mather, K. Ringheim, and E. Zuehlke, “World Population Highlights: Key Findings From PRB's 2010 World Population Data Sheet,” Population Bulletin 65, no. 2 (2010): 1–12.

[40] C. de Martel, J. Ferlay, S. Franceschi, et al., “Global Burden of Cancers Attributable to Infections in 2008: A Review and Synthetic Analysis,” Lancet Oncology 13, no. 6 (2012): 607–615.

[41] J. P. Higgins and S. G. Thompson, “Quantifying Heterogeneity in a Meta-Analysis,” Statistics in Medicine 21, no. 11 (2002): 1539–1558.

[42] W. Chen, C. Xia, R. Zheng, et al., “Disparities by Province, Age, and Sex in Site-Specific Cancer Burden Attributable to 23 Potentially Modifiable Risk Factors in China: A Comparative Risk Assessment,” Lancet Global Health 7, no. 2 (2019): e257–e269.

[43] B. Hollis, F. R. Day, A. S. Busch, et al., “Genomic Analysis of Male Puberty Timing Highlights Shared Genetic Basis With Hair Colour and Lifespan,” Nature Communications 11, no. 1 (2020): 1536.

[44] A. Harroud, J. A. Morris, V. Forgetta, et al., “Effect of Age at Puberty on Risk of Multiple Sclerosis: A Mendelian Randomization Study,” Neurology 92, no. 16 (2019): e1803–e1810.

[45] S. Feng, T. Wang, Y. Su, et al., “Global Burden, Risk Factors, and Projections of Early-Onset Dementia: Insights From the Global Burden of Disease Study 2021,” Ageing Research Reviews 104 (2025): 102644.

[46] N. Galant, P. Krawczyk, M. Monist, et al., “Molecular Classification of Endometrial Cancer and Its Impact on Therapy Selection,” International Journal of Molecular Sciences 25, no. 11 (2024): 5893.

[47] M. L. Levin, “The Occurrence of Lung Cancer in Man,” Acta - Unio Internationalis Contra Cancrum 9, no. 3 (1953): 531–541.

RIGHTS & PERMISSIONS

2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.